Author:
Dassie Justin P,Liu Xiu-ying,Thomas Gregory S,Whitaker Ryan M,Thiel Kristina W,Stockdale Katie R,Meyerholz David K,McCaffrey Anton P,McNamara James O,Giangrande Paloma H
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference48 articles.
1. Mendenhall, W.M., Henderson, R.H. & Mendenhall, N.P. Definitive radiotherapy for prostate cancer. Am. J. Clin. Oncol. 31, 496–503 (2008).
2. Potvin, K. & Winquist, E. Hormone-refractory prostate cancer: a primer for the primary care physician. Can. J. Urol. 15 Suppl 1, 14–20 (2008).
3. Bumcrot, D., Manoharan, M., Koteliansky, V. & Sah, D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711–719 (2006).
4. Aagaard, L. & Rossi, J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 59, 75–86 (2007).
5. de Fougerolles, A., Vornlocher, H.P., Maraganore, J. & Lieberman, J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6, 443–453 (2007).
Cited by
487 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献